Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.

@article{Sakuragi2000ComplicationsRT,
  title={Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.},
  author={Noriaki Sakuragi and Akihito Nakajima and Eiji Nomura and Nobuhiro Noro and Hidekazu Yamada and Ritsu Yamamoto and Seiichiro Fujimoto},
  journal={Gynecologic oncology},
  year={2000},
  volume={79 3},
  pages={420-3}
}
BACKGROUND Complications associated with intraperitoneal (ip) chemotherapy is one of the factors that should be taken into consideration upon performing long-term intraperitoneal administration of chemotherapeutic agents for ovarian carcinoma. METHODS From 1987 to 1996, 78 patients with primary ovarian carcinoma were treated with a total of 365 courses of ip administration of cisplatin (CDDP) or carboplatin (CBDCA) as a part of an initial chemotherapy regimen in combination with surgery… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group • 2018

Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society • 2016

Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society • 2008

Similar Papers

Loading similar papers…